XOMA stock forecast
Our latest prediction for XOMA Corp.'s stock price was made on the Sept. 23, 2020 when the stock price was at 18.25$.
In the short term (2weeks), XOMA's stock price should underperform the market by -0.48%. During that period the price should oscillate between -8.79% and +10.40%.
In the medium term (3months), XOMA's stock price should underperform the market by -9.80%. During that period the price should oscillate between -29.76% and +22.49%.Get email alerts
Create a solid portfolio with XOMA
About XOMA Corp.
XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
At the moment the company generates 11M USD in revenues.
On its last earning announcement, the company reported a loss of -0.94$ per share.
The book value per share is 0.14$
Three months stock forecastSept. 23, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|